0
2. 1. 2026.
Cross-presentation of dead cell-associated antigens shapes the neoantigenic landscape of tumor immunity.
Cross-presentation of dead cell-associated antigens shapes the neoantigenic landscape of tumor immunity.
Ova stranica koristi kolačiće da bi vam pružila najbolje iskustvo
Saznaj više